Page last updated: 2024-08-22

clodronic acid and Jaw Diseases

clodronic acid has been researched along with Jaw Diseases in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Halling, F; Lux, C; Otto, M; Schlittenbauer, T; Ziebart, T1
McCaul, JA1
Ekanayake, K; Omer, O; Polyzois, I; Rice, N; Stassen, LF1
Alons, K; de Jong, E; Kuijpers, SC; van Merkesteyn, JP1
Bauss, F; Drosse, I; Ehrenfeld, M; Opelz, C; Otto, S; Pautke, C; Schieker, M; Schwager, J; Westphal, I1
Erskine, JG; McQuaker, IG; Montazeri, AH1
Colella, G; Guida, L; Pozzuoli, G1

Reviews

2 review(s) available for clodronic acid and Jaw Diseases

ArticleYear
Pharmacologic modalities in the treatment of osteoradionecrosis of the jaw.
    Oral and maxillofacial surgery clinics of North America, 2014, Volume: 26, Issue:2

    Topics: Anti-Bacterial Agents; Antioxidants; Bone Density Conservation Agents; Chemoradiotherapy; Clodronic Acid; Combined Modality Therapy; Humans; Hyperbaric Oxygenation; Jaw Diseases; Orthognathic Surgical Procedures; Osteoradionecrosis; Pentoxifylline; Plastic Surgery Procedures; Radiation-Protective Agents; Tocopherols

2014
The management of osteoradionecrosis of the jaws--a review.
    The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 2015, Volume: 13, Issue:2

    Topics: Algorithms; Anti-Inflammatory Agents; Clodronic Acid; Fibrosis; Head and Neck Neoplasms; Humans; Hyperbaric Oxygenation; Jaw Diseases; Osteoradionecrosis; Pentoxifylline; Radiation-Protective Agents; Radiotherapy; Tocopherols

2015

Other Studies

5 other study(ies) available for clodronic acid and Jaw Diseases

ArticleYear
Geranyl-geraniol addition affects potency of bisphosphonates-a comparison in vitro promising a therapeutic approach for bisphosphonate-associated osteonecrosis of the jaw and oral wound healing.
    Oral and maxillofacial surgery, 2022, Volume: 26, Issue:2

    Topics: Acyclic Monoterpenes; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Clodronic Acid; Diphosphonates; Endothelial Cells; Humans; Ibandronic Acid; Jaw Diseases; Mouth Diseases; Osteonecrosis; Wound Healing; Zoledronic Acid

2022
Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2009, Volume: 107, Issue:2

    Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Bone Density Conservation Agents; Chronic Disease; Clinical Protocols; Clodronic Acid; Debridement; Dental Implants; Diphosphonates; Female; Humans; Injections, Intravenous; Jaw Diseases; Middle Aged; Osteomyelitis; Osteonecrosis; Pamidronate; Retrospective Studies; Tooth Extraction

2009
Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2010, Volume: 68, Issue:11

    Topics: Bone Density Conservation Agents; Cell Line; Cell Movement; Cell Proliferation; Cell Shape; Cell Survival; Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Ibandronic Acid; Imidazoles; Jaw Diseases; Mesenchymal Stem Cells; Osteonecrosis; Time Factors; Zoledronic Acid

2010
Oral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma.
    European journal of haematology, 2007, Volume: 79, Issue:1

    Topics: Adult; Clodronic Acid; Humans; Jaw Diseases; Male; Multiple Myeloma; Osteonecrosis

2007
[The involvement of the oromaxillofacial area in secondary hyperparathyroidism].
    Minerva stomatologica, 1990, Volume: 39, Issue:12

    Topics: Chronic Disease; Clodronic Acid; Combined Modality Therapy; Face; Female; Humans; Hyperparathyroidism, Secondary; Jaw Diseases; Middle Aged; Mouth Diseases; Parathyroidectomy

1990